- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.01. | After phase 3 setbacks, troubled Marinus inks $151M sale to Immedica Pharma | ||
| 02.01. | With $608M divestment, Hutchmed continues to focus on ADC development | ||
| 02.01. | Pfizer, BMS and more ring in 2025 with fresh round of drug price increases: report | ||
| 02.01. | Lilly's Zepbound expected to surpass Novo's Wegovy to 'dominate' obesity market: GlobalData | ||
| 02.01. | Bristol Myers celebrates 10 years of Opdivo with FDA approval for subcutaneous version | ||
| 19.12.24 | Sanofi and Regeneron's Dupixent, Leo Pharma's Anzupgo could help close treatment gap in chronic hand eczema: GlobalData | ||
| 19.12.24 | FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs | ||
| 19.12.24 | Klick Health goes on a hiring spree to close out the year, adding 22 new leaders | ||
| 19.12.24 | After two rejections, FDA approves Mesoblast's first-of-its-kind cell therapy | ||
| 19.12.24 | Playing catch-up with Pfizer and Roche, China-made ALK drug clears FDA in lung cancer | ||
| 19.12.24 | Novartis to shutter 2 MorphoSys sites, lay off 330 staffers in post-buyout consolidation | ||
| 19.12.24 | Analysts tip BMS' Cobenfy to be top dog in growing schizophrenia market | ||
| 18.12.24 | Takeda casts a new line with first DTC campaign for HyQvia in CIDP | ||
| 18.12.24 | Trio of drugmakers issue drug recalls tied to impurity, labeling issues | ||
| 18.12.24 | African Union gains $45M package to boost vaccine manufacturing in Senegal | ||
| 18.12.24 | India's ACG kicks off operations at mammoth capsule plant in Thailand | ||
| 18.12.24 | Regeneron's Eylea HD passes key test in retinal vein occlusion, teeing up 2025 FDA filing as Eylea threats mount | ||
| 17.12.24 | CMI Media Group taps Anoki AI to fine-tune pharma ad targeting | ||
| 17.12.24 | After studies flag possible link between Novo's Ozempic and rare eye disorder, Danish agency calls for probe | ||
| 17.12.24 | Pfizer CEO says he developed 'good relation' with RFK Jr., highlights Trump's pride in vaccine work | ||
| 17.12.24 | Doctors weigh in on GLP-1s: The impact of celeb endorsements, the indications they're hoping for and more | ||
| 17.12.24 | Sandoz shells out $275M in latest effort to move past 'legacy' price-fixing litigation | ||
| 17.12.24 | Cozadd's coda: Jazz unveils succession plan as longtime CEO and co-founder plots retirement | ||
| 17.12.24 | Pfizer expects $1B hit from IRA's Part D redesign and no major M&A in 2025 | ||
| 17.12.24 | FDA rejects J&J's subcutaneous Rybrevant filing and AstraZeneca's full approval bid for Andexxa |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
